PHARMAID

Pharmaids Pharmaceuticals Ltd.

BSE: 524572

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

29.00+0.5 (+1.75%)

23 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

4.4 / 100

Value Score

10.1 / 100

Price Momentum Score

26.2 / 100

QVM Score

2.6 / 100

Key Metrics

Market Cap

102.28

P/E (TTM)

P/B

2.15

P/S (TTM)

4.04

EV/EBITDA

CAPE (5Y)

ROE (TTM)

-21.91

ROCE (TTM)

-18.87

ROA (TTM)

-11.31

Avg 3Y ROE

-18.39

Earnings 3Y CAGR

35.67

Sales 3Y CAGR

Sales 5Y CAGR

18.40

Debt/Equity

0.49

Consensus TP

Strong Buy %

Promoter Holding

32.99

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Pharmaids Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -4.79% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Weak price momentum

Price Momentum score of 26.2 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

26.2 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 58.2 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

58.2 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Pharmaids Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Pharmaids Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Pharmaids Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Total Promoter	2.19	2.19	65.90	65.84	65.81	65.80	65.65	55.56	35.44	20.70	20.97	16.54	9.95	9.94	9.70	9.25	5.64	5.56	5.19	5.22	5.22	5.14	32.99	32.99	32.99	32.99	32.99
Indian Promoter	2.19	2.19	65.90	65.84	65.81	65.80	65.65	55.56	35.44	20.70	20.97	16.54	9.95	9.94	9.70	9.25	5.64	5.56	5.19	5.22	5.22	5.14	32.99	32.99	32.99	32.99	32.99
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	97.81	97.81	34.10	34.16	34.19	34.20	34.35	44.44	64.56	79.30	79.03	83.46	90.05	90.06	90.30	90.75	94.36	94.44	94.81	94.78	94.78	94.86	67.01	67.01	67.01	67.01	67.01
Bodies Corporate	-	0.43	0.40	-	-	-	-	-	-	-	0.32	1.48	0.91	0.90	0.22	0.17	4.54	4.54	4.63	4.87	4.79	4.76	0.35	0.39	0.36	0.35	0.35
Others (incl. Retail) No. of shareholders	97.81 4,620	97.38 4,612	33.70 4,694	34.16 5,198	34.19 5,836	34.20 7,167	34.35 7,307	44.44 8,290	64.56 9,596	79.30 9,471	78.71 9,150	81.98 8,147	89.14 7,714	89.16 7,431	90.08 7,350	90.58 7,239	89.82 7,527	89.90 7,553	90.18 8,010	89.91 8,306	89.99 8,181	90.10 7,995	66.66 8,005	66.62 8,266	66.65 8,381	66.66 8,605	66.66 8,693

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Pharmaids Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
SHANKARAPPA NAGARAJA VINAYA BABU Director	September-2025	Off Market (Acquisition) 15th Sep 2025	27.59 %	₹ 35.00	1.00 lac	₹ 35.00 lac
MALIEMADOM RAMASWAMY IYER MAHADEVAN Designated Person	September-2025	Market Sale (Disposal) 2nd Sep 2025	0.36 %	₹ 61.50	4.00 k	₹ 2.46 lac
Venkata Rao Sadhanala Promoter	July-2025	Market Sale (Disposal) 2nd Jul 2025	4.39 %	₹ 58.26	25.01 k	₹ 14.57 lac
MALIEMADOM RAMASWAMY IYER MAHADEVAN Designated Person	June-2025	Market Sale (Disposal) 18th Jun 2025	0.88 %	₹ 58.29	31.94 k	₹ 18.62 lac
MALIEMADOM RAMASWAMY IYER MAHADEVAN Employee	January-2025	Market Sale (Disposal) 1st Jan 2025	0.94 %	₹ 61.49	20.98 k	₹ 12.90 lac
Shreedhara Shetty Director	December-2024	Market Sale (Disposal) 31st Dec 2024	17.41 %	₹ 63.94	1.28 lac	₹ 81.89 lac
Shreedhara Shetty Director	December-2024	Market Sale (Disposal) 31st Dec 2024	17.41 %	₹ 63.94	1.28 lac	₹ 81.89 lac
Shreedhara Shetty Director	December-2024	Market Sale (Disposal) 26th Dec 2024	17.62 %	₹ 60.90	76.80 k	₹ 46.77 lac
Dr. Shankarappa Nagaraja Vinaya Babu Director	December-2024	Market Sale (Acquisition) 23rd Dec 2024	14.74 %	₹ 25.00	18.21 lac	₹ 4.55 cr
Shreedhara Shetty Director	December-2024	Market Sale (Disposal) 20th Dec 2024	17.69 %	₹ 58.47	23.81 k	₹ 13.92 lac

…

No corporate action data available.

Company Profile

Overview of Pharmaids Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and int...

Key personnel

Mr. Balagangadhara B C

Chief Financial Officer

Mr. Prasanna Subramanya Bhat

Compliance Officer and Company Secretary

Mr. Pattamadai Natarajasarma VijayD

Non-Executive Independent Chairman of the Board

Mr. Shankarappa Nagaraja Vinaya BabuD

Non-Executive Vice Chairman of the Board

Shri. Subhash JainD

Executive and Non Independent Director

Mrs. S. Padmaja KalyaniD

Additional Non-Independent Executive Director

Mr. Venu Madhava KaparthysD

Whole-Time Director

Ms. Mini ManikantansD

Whole Time Director

View all

Incorporated on

01 Mar 1989

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

27 Apr 1994

Free Float

90,60,368

Website

http://www.pharmaids.com/

Phone no.

+918049784319

Address

Unit 201, 2nd Floor, Brigade Rubix, 20/14, HMT Watch Factory, Peenya Plantation, BANGALORE, 560013, India

Frequently Asked Questions

What is the current share price of Pharmaids Pharmaceuticals Ltd.?

The current share price of Pharmaids Pharmaceuticals Ltd. is ₹ 29.00 as of 23 Oct 2026.

What is the market capitalisation of Pharmaids Pharmaceuticals Ltd.?

The market capitalisation of Pharmaids Pharmaceuticals Ltd. stands at ₹ 102.28 Cr.

What is the PE ratio of Pharmaids Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of Pharmaids Pharmaceuticals Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Pharmaids Pharmaceuticals Ltd.?

Pharmaids Pharmaceuticals Ltd. has a Return on Equity (ROE) of -21.91% and a Return on Capital Employed (ROCE) of -18.87% as per the latest financial reports.

What is the 52-week high and low of Pharmaids Pharmaceuticals Ltd.?

The 52-week high of Pharmaids Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of Pharmaids Pharmaceuticals Ltd.?

The dividend yield of Pharmaids Pharmaceuticals Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Pharmaids Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 66.66% of Pharmaids Pharmaceuticals Ltd. shares.

What sector does Pharmaids Pharmaceuticals Ltd. belong to?

Pharmaids Pharmaceuticals Ltd. operates in the Healthcare sector.

What is the beta of Pharmaids Pharmaceuticals Ltd.?

The beta of Pharmaids Pharmaceuticals Ltd. is 0.75, indicating its price volatility relative to the broader market. Over the past 1 year, Pharmaids Pharmaceuticals Ltd. has delivered an absolute return of -38.87%.

What is the RSI of Pharmaids Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of Pharmaids Pharmaceuticals Ltd. is 40.18, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.